Real estate for vascular surgeons

Vascular surgery income supports aggressive real estate. Here’s the playbook.

As a vascular surgeon, your financial life is fundamentally different from that of other physicians. The combination of high W-2 income, potential for 1099 work, and, most critically, opportunities for equity in surgical groups and ambulatory surgery centers (ASCs) creates a unique set of challenges and advantages. Standard-issue financial advice often misses the mark. You’re not just saving for retirement; you’re managing a high-velocity cash flow machine that demands sophisticated tax and operational strategy. Real estate isn’t just a place to live or a passive investment—it’s an active tool for wealth creation and tax mitigation that integrates directly with your practice.

Most of us learn this the hard way, by overpaying taxes for years before realizing the strategies our senior partners were using. This is the playbook to accelerate that learning curve. We’ll move past the basics and into the specific, high-impact structures that leverage your unique position as a surgeon-owner. For a broader overview of practice models and compensation, you can always reference the main vascular surgery resources hub, but here, we focus on the real estate-centric playbook that can redefine your financial trajectory.

Commercial Medical Real Estate: Becoming Your Practice’s Landlord

One of the most powerful and common strategies for surgical partners is to own the real estate where the practice operates. Instead of your practice paying rent to an unrelated third-party landlord, it pays rent to a separate company that you own. This simple shift transforms a pure expense into a wealth-building and tax-shielding mechanism.

Here’s the structure:

1. Form a Holding Company: You and your partners form a separate Limited Liability Company (LLC)—let’s call it “Vascular Properties, LLC”—distinct from your medical practice entity.
2. Acquire the Asset: Vascular Properties, LLC purchases the medical office building or suite.
3. Execute a Lease: Your medical practice (e.g., “Vascular Surgeons, PA”) signs a formal, market-rate triple-net (NNN) lease agreement with Vascular Properties, LLC.

The magic happens in the tax code. The rent paid by the practice is a fully deductible business expense, reducing the practice’s taxable income. That rent becomes income for your real estate LLC, but this is where the strategy deepens. The LLC can depreciate the value of the commercial building over 39 years, creating a large “paper loss” that shields the rental income from tax. But the real accelerator is pairing this with Real Estate Professional Status (REPS) for a spouse.

Under IRS rules, if your spouse (filing jointly) spends more than 750 hours per year and more than 50% of their total working time on real estate activities (managing properties, dealing with tenants, overseeing renovations), they can qualify for REPS. This is a game-changer. With REPS, the “paper losses” from your real estate—supercharged by depreciation—are no longer considered “passive.” They become active losses that can be used to directly offset your high active income from surgery. A large depreciation loss from the building can wipe out a significant portion of your W-2 or 1099 income, resulting in massive tax savings.

The Planning Trap: The self-rental rule under IRC §469. If you own and materially participate in both the practice and the real estate entity but your spouse does not qualify for REPS, the rental income is classified as non-passive, but any losses are considered passive. This mismatch prevents you from using those real estate losses to offset your surgical income. Achieving REPS for a spouse is the key that unlocks the full tax-shielding power of this strategy.

Supercharging Deductions with Cost Segregation Studies

Owning your medical office is powerful. Supercharging its depreciation is transformative. A cost segregation study is an engineering-based analysis that reclassifies components of your property to accelerate depreciation deductions, generating massive paper losses in the early years of ownership.

Normally, a commercial building is depreciated on a straight-line basis over 39 years. A cost segregation study dissects the building and identifies assets that can be depreciated over much shorter periods—typically 5, 7, or 15 years. These components include things like specialty electrical wiring for medical equipment, plumbing, cabinetry, carpeting, security systems, and exterior landscaping.

Here’s a concrete example:

• You and your partners buy a medical office building for $3 million (excluding land value).
• Without Cost Segregation: Your annual depreciation deduction is roughly $76,923 ($3M / 39 years).
• With Cost Segregation: The engineering firm might determine that 25% of the building’s cost ($750,000) can be reclassified as 5-year and 15-year property.

Under current tax law (which can change), you may be able to apply 100% bonus depreciation to these shorter-lived assets. This means you could potentially take a $750,000 depreciation deduction in Year 1, instead of $76,923. This creates a colossal paper loss that, if you have REPS, can flow through to offset your surgical income. You can model how such a large upfront deduction impacts your projected returns and cash flow with a detailed real estate investing calculator.

The Planning Trap: Depreciation recapture. Cost segregation is a tax deferral strategy, not a tax elimination strategy. When you eventually sell the property, the IRS “recaptures” the depreciation you took, and it’s taxed—some of it at higher ordinary income rates. The strategic value lies in the time value of money: you get a massive, interest-free loan from the government, which you can reinvest and grow for decades. The goal is to generate returns on that deferred tax that far outpace the future tax bill.

ASC Ownership: K-1s, Basis, and the Active vs. Passive Game

For many vascular surgeons, a major wealth driver is equity in an Ambulatory Surgery Center (ASC) or Office-Based Lab (OBL). This ownership interest flows income to you via a Schedule K-1, which operates under a different set of rules than W-2 salary.

When you buy into an ASC, you establish your “basis”—essentially your financial stake in the partnership. Your basis is increased by capital contributions and your share of profits, and it’s decreased by distributions and your share of losses. You can only deduct losses up to your basis, a concept known as the basis limitation.

The critical distinction for surgeons is whether your participation in the ASC is “active” or “passive.” According to the passive activity rules under IRC §469, if you “materially participate” in the business, your income and losses are active. Material participation is typically met by surgeons who are heavily involved in the ASC’s operations and perform procedures there. This is good news: it means if the ASC has a loss (common in early years due to high startup costs and accelerated equipment depreciation), you can use that loss to offset your other active income.

The Planning Trap: At-Risk Rules. Beyond the basis limitation, your deductible losses are also limited to the amount you are “at-risk.” This is generally the cash you’ve contributed plus any debt you are personally liable for. If you buy into an ASC using non-recourse debt (debt for which you are not personally on the hook), your at-risk amount may be lower than your basis, potentially limiting your ability to deduct losses in a given year. It’s crucial to understand the financing structure of your buy-in and how it impacts both your basis and your at-risk amount.

The 199A QBI Deduction: A Warning for High Earners

The Qualified Business Income (QBI) deduction, created by the Tax Cuts and Jobs Act of 2017 under Section 199A, was designed to give pass-through businesses a 20% deduction on their income. However, for physicians, it comes with a major catch.

Medicine is classified as a “Specified Service Trade or Business” (SSTB). This means that once your taxable income exceeds a certain threshold, the QBI deduction begins to phase out and is eventually eliminated entirely. For 2026, these thresholds will be inflation-adjusted, but they are far below the typical income of a partner-track vascular surgeon. As of the mid-2020s, the phase-out range ends at a taxable income of $464,900 for married couples filing jointly.

Most established vascular surgeons will have income well above this limit. The takeaway is simple: do not count on the 199A QBI deduction.

When you hear financial advisors talk about the “20% pass-through deduction,” you should immediately recognize that it likely does not apply to your primary surgical income from your practice or ASC. This isn’t a failure of planning; it’s a feature of the tax code.

The Planning Trap: Believing you can structure your way into the QBI deduction. Some advisors have proposed complex and aggressive strategies to de-couple “service” income from other business activities (a “crack-and-pack” strategy). The IRS has aggressively scrutinized these arrangements. For a surgeon, the risk of an audit and penalties far outweighs the potential benefit. Instead of chasing a deduction you’re legislated out of, your time and capital are better spent focusing on the other strategies discussed here: commercial real estate, cost segregation, and maxing out tax-deferred retirement accounts.

Cash Balance Plans: The Ultimate Pre-Tax Shelter

While not a real estate strategy, this is the single most powerful retirement savings tool for high-income surgeons and it works in concert with a real estate portfolio by dramatically reducing your taxable income, freeing up cash flow for investment.

A cash balance plan is a type of IRS-qualified defined benefit pension plan. It allows for massive pre-tax contributions that dwarf those of a 401(k). While a 401(k) profit-sharing plan might cap your total annual contributions around $70,000 (depending on the year), a cash balance plan can be stacked on top of it, allowing you to contribute an additional $100,000 to $300,000+ per year, pre-tax.

The contribution amount is determined by an actuary and is based on your age, income, and other factors. The older you are, the more you can contribute. For a surgeon in their late 40s or 50s, it’s not uncommon to shelter over $350,000 per year between a 401(k) and a cash balance plan. At a 40% marginal federal and state tax rate, that’s $140,000 in immediate, direct tax savings each year.

This strategy is particularly effective for small surgical groups and solo practitioners who can design a plan that maximizes benefits for the partners. The contributions are a required, annual commitment, so stable, high cash flow is a prerequisite—a perfect fit for an established vascular surgery practice. You can find detailed breakdowns of these plans and their contribution limits in public sources like the Repit data repository on retirement plans.

The Planning Trap: Underfunding or inconsistent funding. Unlike a 401(k), where you can change your contribution amount easily, a cash balance plan has a mandatory funding requirement calculated by the actuary. Failing to make the contribution can result in penalties. This makes the strategy best suited for surgeons with predictable, high income who are committed to saving aggressively for the long term.

The strategies outlined here—owning your medical real estate, leveraging cost segregation, understanding your K-1s, and maximizing pre-tax retirement savings—form the core of a sophisticated financial plan for a vascular surgeon. They move beyond generic advice and utilize the specific financial and operational realities of your career to build wealth and dramatically reduce your tax burden.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 21, 2026